The Registry of Toxic Effects of Chemical Substances
Chloroform |
UPDATE: May 2005 | MW: 119.37 | MF: CHCl3 |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
148 mg
|
N/R
|
AIHAAP 37,697,1976
|
eye | rabbit
20 mg/24 hour
|
moderate
|
85JCAE -,89,1986
|
skin | rabbit
10 mg/24 hour open irritation test
|
mild
|
AIHAAP 23,95,1962
|
skin | rabbit
500 mg/24 hour
|
mild
|
85JCAE -,89,1986
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
oral | mouse
0.5 ppb
|
EMMUEG 39,69,2002
|
cytogenetic analysis
|
intraperitoneal | rat
1,200 µg/kg
|
MUREAV 242,111,1990
|
cytogenetic analysis
|
oral | rat
597 mg/kg/5 day- intermittent
|
MUREAV 242,111,1990
|
cytogenetic analysis
|
oral | rat
0.5 ppb
|
EMMUEG 39,69,2002
|
DNA adduct
|
mammal (species unspecified)
lymphocyte
|
1 mmol/L
|
TOLED5 11,243,1982
|
DNA damage
|
human
lung
|
100 µmol/L/3 hour
|
MUREAV 538,41,2003
|
DNA damage
|
mouse
mammary gland
|
3.8 mmol/L/2 hour
|
TOXID9 72,203,2003
|
DNA damage
|
rat
mammary gland
|
3.8 mmol/L/2 hour
|
TOXID9 72,203,2003
|
DNA damage
|
rat
liver
|
8 mmol/L/2 hour
|
TXCYAC 187,101,2003
|
DNA inhibition
|
human
HeLa cell
|
19 mmol/L
|
CRNGDP 13,2389,1992
|
DNA repair
|
Escherichia coli
|
500 mg/L
|
PMRSDJ 1,195,1981
|
DNA repair
|
Saccharomyes cerevisiae
|
100 mg/L
|
PMRSDJ 1,502,1981
|
unscheduled DNA synthesis
|
intraperitoneal | mouse
50 mg/kg
|
TOLED5 21,357,1984
|
unscheduled DNA synthesis
|
oral | rat
1 gm/kg
|
MUREAV 320,189,1994
|
mutation in microorganisms
|
mouse
lymphocyte
|
12 mg/L (+enzymatic activation step)
|
EMMUEG 12(Suppl 13),103,1988
|
mutation in microorganisms
|
Salmonella typhimurium
|
20 µg/plate (+/-enzymatic activation step)
|
PMRSDJ 1,280,1981
|
mutation in microorganisms
|
Schizosaccharomyces pombe
|
5 mg/L (+enzymatic activation step)
|
PMRSDJ 1,424,1981
|
micronucleus test
|
oral | rat
4 mmol/kg
|
MUREAV 413,1,1998
|
gene conversion and mitotic recombination
|
Saccharomyes cerevisiae
|
2,980 mg/L
|
MUREAV 397,271,1998
|
mutation in mammalian somatic cells
|
hamster
lung
|
1 mg/L
|
BLFSBY 39,359,1986
|
morphological transform
|
hamster
kidney
|
4,430 mg/L
|
PMRSDJ 1,626,1981
|
morphological transform
|
mouse
fibroblast
|
0.1 pph/21 day (-enzymatic activation step)
|
EMMUEG 35,300,2000
|
other mutation test systems
|
inhalation | grasshopper
15 pph/16 hour
|
MUREAV 113,467,1983
|
other mutation test systems
|
hamster
fibroblast
|
1 pph
|
ANESAV 43,21,1975
|
sister chromatid exchange
|
hamster
embryo
|
100 µmol/L
|
SHIGAZ 74,1385,1987
|
sister chromatid exchange
|
human
lymphocyte
|
10 mmol/L
|
ENVRAL 32,72,1983
|
sister chromatid exchange
|
inhalation | mouse
300 ppm/6 hour
|
IGAYAY 122,978,1982
|
sister chromatid exchange
|
oral | mouse
200 mg/kg/4 day- intermittent
|
ENVRAL 32,72,1983
|
sister chromatid exchange
|
rat
leukocyte
|
1 mmol/L
|
MUREAV 300,241,1993
|
sex chromosome loss and nondisjunction
|
hamster
lung
|
60 mmol/L
|
MUREAV 182,135,1987
|
specific locus test
|
oral | mouse
0.5 ppb
|
EMMUEG 39,69,2002
|
specific locus test
|
oral | rat
0.5 ppb
|
EMMUEG 39,69,2002
|
sperm morphology
|
inhalation | mouse
400 ppm/4 hour/5 day- intermittent
|
ANESAV 54,53,1981
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lowest published toxic concentration: 100 ppm/7 hour (1-7 day pregnant)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
TXAPA9 50,515,1979
|
inhalation | mouse
lowest published toxic concentration: 100 ppm/7 hour (8-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
TXAPA9 50,515,1979
|
inhalation | rat
lowest published toxic concentration: 30 ppm/7 hour (6-15 day pregnant)
|
Reproductive: Effects on fertility: Other measures of fertility | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Specific developmental abnormalities: Musculoskeletal system
TXAPA9 28,442,1974
|
inhalation | rat
lowest published toxic concentration: 100 ppm/7 hour (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Gastrointestinal system | Reproductive: Specific developmental abnormalities: Homeostasis
TXAPA9 28,442,1974
|
inhalation | rat
lowest published toxic concentration: 300 ppm/7 hour (6-15 day pregnant)
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
TXAPA9 28,442,1974
|
inhalation | rat
lowest published toxic concentration: 20,100 µg/m3/1 hour (7-14 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Effects on embryo or fetus: Fetal death
NTIS** PB277-077
|
oral | mouse
lowest published toxic dose: 2,177 mg/kg (3 week male/3 week prior to copulation-7 day after birth)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Biochemical and metabolic
NETOD7 1,199,1979
|
oral | mouse
lowest published toxic dose: 2,115 mg/kg (3 week male/3 week prior to copulation-5 day after birth)
|
Reproductive: Effects on newborn: Other postnatal measures or effects
|
EVHPAZ 46,127,1982
|
oral | rat
lowest published toxic dose: 1,260 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
TXAPA9 29,348,1974
|
oral | rat
lowest published toxic dose: 4 gm/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
JPFCD2 18,333,1983
|
oral | rat
lowest published toxic dose: 41 mg/kg (multigenerations)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
NTIS** #PB89148639
|
oral | rabbit
lowest published toxic dose: 260 mg/kg (6-18 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
TXAPA9 29,348,1974
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 127 gm/kg/92 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
NCITR* NCI-TR-0,1976
|
oral | mouse
toxic dose : 18 gm/kg/17 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Liver: Tumors
JNCIAM 5,251,1945
|
oral | mouse
toxic dose : 24,752 mg/kg/2 year- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors
FAATDF 5,760,1985
|
oral | mouse
toxic dose : 130 gm/kg/2 year- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Liver: Tumors Kidney, Ureter, and Bladder: Bladder tumors
VOONAW 33(8),81,1987
|
oral | rat
lowest published toxic dose: 13,832 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Blood: Leukemia
FAATDF 5,760,1985
|
oral | rat
toxic dose : 98 gm/kg/78 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors Endocrine: Thyroid tumors
NCITR* NCI-TR-0,1976
|
oral | rat
toxic dose : 7,020 mg/kg/78 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Kidney, Ureter, and Bladder: Kidney tumors
EVHPAZ 31,171,1979
|
oral | rat
toxic dose : 70 gm/kg/78 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors Endocrine: Thyroid tumors
NCITR* NCI-TR-0,1976
|
oral | rat
toxic dose : 58,968 mg/kg/2 year- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Endocrine: Thyroid tumors Blood: Tumors
FAATDF 5,760,1985
|
oral | rat
lowest published toxic dose: 88.2 gm/kg/100 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
TOXID9 72,84,2003
|
oral | rat
lowest published toxic dose: 48 gm/kg/16 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors Tumorigenic: Increased incidence of tumors in susceptible strains
TXCYAC 187,1,2003
|
oral | rat
lowest published toxic dose: 216 gm/kg/16 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors Tumorigenic: Increased incidence of tumors in susceptible strains
TXCYAC 187,1,2003
|
oral | rat
lowest published toxic dose: 675 gm/kg/40 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Kidney, Ureter, and Bladder: Kidney tumors Tumorigenic: Increased incidence of tumors in susceptible strains
TXCYAC 187,1,2003
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | cat
lowest published lethal concentration: 35 gm/m3/4 hour
|
Behavioral: General anesthetic | Gastrointestinal: Changes in structure or function of salivary glands Gastrointestinal: Nausea or vomiting
AHBAAM 116,131,1936
|
inhalation | cat
lowest published toxic concentration: 30,000 mg/m3/3 hour
|
Behavioral: General anesthetic
|
VCVGH* -,330,1990
|
inhalation | cat
lowest published toxic concentration: 70,000 mg/m3/40 minute
|
Behavioral: General anesthetic
|
VCVGH* -,330,1990
|
inhalation | dog
lowest published lethal concentration: 100 gm/m3
|
N/R
|
PCOC** -,230,1966
|
inhalation | dog
lowest published toxic concentration: 80,000 mg/m3
|
Behavioral: General anesthetic
|
VCVGH* -,330,1990
|
inhalation | frog
lowest published lethal concentration: 6 gm/m3
|
N/R
|
AEXPBL 97,86,1923
|
inhalation | guinea pig
lowest published lethal concentration: 20,000 ppm/2 hour
|
N/R
|
FLCRAP 1,197,1967
|
inhalation | guinea pig
lowest published toxic concentration: 33,000 mg/m3
|
Behavioral: General anesthetic
|
VCVGH* -,330,1990
|
inhalation | human
lowest published toxic concentration: 10 mg/m3/1 year
|
Behavioral: Anorexia (human) | Gastrointestinal: Nausea or vomiting Gastrointestinal: Other changes
IRGGAJ 24,127,1967
|
inhalation | human
lowest published lethal concentration: 25,000 ppm/5 minute
|
N/R
|
TABIA2 3,231,1933
|
inhalation | human
lowest published toxic concentration: 5,000 mg/m3/7 minute
|
Behavioral: Hallucinations, distorted perceptions
|
AHBAAM 116,131,1936
|
inhalation | mammal (species unspecified)
lowest published lethal concentration: 25,000 ppm/5 minute
|
N/R
|
AEPPAE 138,65,1928
|
inhalation | mouse
lowest published lethal concentration: 23 gm/m3/56 minute
|
Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change | Behavioral: General anesthetic Behavioral: Change in motor activity (specific assay)
BIZEA2 115,235,1921
|
inhalation | mouse
lowest published toxic concentration: 20,000 mg/m3/2 hour
|
Behavioral: General anesthetic
|
VCVGH* -,307,1990
|
inhalation | mouse
lethal concentration (50 percent kill): 17,200 mg/m3/2 hour
|
N/R
|
VCVGH* -,330,1990
|
inhalation | mouse
lethal concentration (16 percent kill): 16,000 mg/m3/2 hour
|
N/R
|
VCVGH* -,330,1990
|
inhalation | mouse
lethal concentration (84 percent kill): 29,000 mg/m3/2 hour
|
N/R
|
VCVGH* -,330,1990
|
inhalation | mouse
lethal concentration (50 percent kill): 6,000 mg/m3/6 hour
|
N/R
|
VCVGH* -,330,1990
|
inhalation | rat
lethal concentration (50 percent kill): 47,702 mg/m3/4 hour
|
N/R
|
ENVRAL 40,411,1986
|
inhalation | rat
lethal concentration (50 percent kill): 6,000 mg/m3/6 hour
|
N/R
|
VCVGH* -,330,1990
|
inhalation | rabbit
lowest published lethal concentration: 59 gm/m3
|
N/R
|
PCOC** -,230,1966
|
intraperitoneal | dog
lethal dose (50 percent kill): 1 gm/kg
|
Liver: Liver function tests impaired
|
TXAPA9 10,119,1967
|
intraperitoneal | mouse
lethal dose (50 percent kill): 623 mg/kg
|
N/R
|
AGGHAR 18,109,1960
|
intraperitoneal | rat
lethal dose (50 percent kill): 894 mg/kg
|
N/R
|
ENVRAL 40,411,1986
|
intraperitoneal | rat
lowest published toxic dose: 0.5 mL/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical: Metabolism (intermediary): Other proteins
TOXID9 72,96,2003
|
intravenous | dog
lowest published lethal dose: 75 mg/kg
|
N/R
|
QJPPAL 7,205,1934
|
oral | dog
lowest published lethal dose: 1 gm/kg
|
N/R
|
QJPPAL 7,205,1934
|
oral | guinea pig
lethal dose (50 percent kill): 820 mg/kg
|
N/R
|
VCVGH* -,330,1990
|
oral | man
lowest published lethal dose: 2,514 mg/kg
|
Behavioral: Muscle contraction or spasticity | Cardiac: Other changes Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)
AJEMEN 6,507,1988
|
oral | mouse
lethal dose (50 percent kill): 36 mg/kg
|
N/R
|
ATSUDG 2,371,1979
|
oral | mouse
lethal dose (16 percent kill): 620 mg/kg
|
N/R
|
VCVGH* -,330,1990
|
oral | mouse
lethal dose (84 percent kill): 1,650 mg/kg
|
N/R
|
VCVGH* -,330,1990
|
oral | rat
lethal dose (50 percent kill): 695 mg/kg
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Ataxia Lung, Thorax, or Respiration: Respiratory stimulation
KHZDAN 29(5),39,1986
|
oral | rat
lethal dose (16 percent kill): 800 mg/kg
|
N/R
|
VCVGH* -,330,1990
|
oral | rat
lethal dose (50 percent kill): 1,250 mg/kg
|
N/R
|
VCVGH* -,330,1990
|
oral | rat
lethal dose (84 percent kill): 985 mg/kg
|
N/R
|
VCVGH* -,330,1990
|
oral | rat
lowest published toxic dose: 0.5 mL/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation)
VCVGH* -,331,1990
|
oral | rabbit
lowest published lethal dose: 500 mg/kg
|
N/R
|
AEXPBL 97,86,1923
|
subcutaneous | mouse
lethal dose (50 percent kill): 704 mg/kg
|
N/R
|
JPETAB 123,224,1958
|
subcutaneous | rabbit
lowest published lethal dose: 800 mg/kg
|
N/R
|
QJPPAL 7,205,1934
|
skin | rabbit
lethal dose (50 percent kill): >20 gm/kg
|
N/R
|
NTIS** AD-A062-138
|
unreported route | human
lethal dose (50 percent kill): 2.9 mL/kg
|
N/R
|
VCVGH* -,331,1990
|
unreported route | human
lowest published toxic dose: 6.3 mg/kg
|
Gastrointestinal: Gastritis | Gastrointestinal: Necrotic changes
VCVGH* -,331,1990
|
unreported route | man
lowest published lethal dose: 546 mg/kg
|
N/R
|
85DCAI 2,73,1970
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | dog
lowest published toxic concentration: 25 ppm/7 hour/26 week- intermittent
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)
|
AIHAAP 37,697,1976
|
inhalation | guinea pig
lowest published toxic concentration: 85 ppm/7 hour/26 week- intermittent
|
Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis)
|
AIHAAP 37,697,1976
|
inhalation | mouse
lowest published toxic concentration: 12 ppm/6 hour/13 week- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
JTSCDR 18,423,1993
|
inhalation | mouse
lowest published toxic concentration: 100 ppm/6 hour/7 day- intermittent
|
Liver: Other changes | Liver: Changes in liver weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
FAATDF 22,431,1994
|
inhalation | mouse
lowest published toxic concentration: 10 ppm/2 day- intermittent
|
Behavioral: Somnolence (general depressed activity)
|
TOSCF2 66,201,2002
|
inhalation | mouse
lowest published toxic concentration: 30 ppm/7 day- intermittent
|
Liver: Hepatitis (hepatocellular necrosis), zonal | Liver: Changes in liver weight Behavioral: Somnolence (general depressed activity)
TOSCF2 66,201,2002
|
inhalation | rat
lowest published toxic concentration: 50 ppm/7 hour/26 week- intermittent
|
Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis) | Liver: Other changes Kidney, Ureter, and Bladder: Changes in bladder weight
AIHAAP 37,697,1976
|
inhalation | rat
lowest published toxic concentration: 90 ppm/6 hour/13 week- intermittent
|
Liver: Hepatitis (hepatocellular necrosis), diffuse | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Nutritional and Gross Metabolic: Weight loss or decreased weight gain
FAATDF 32,109,1996
|
inhalation | rat
lowest published toxic concentration: 300 ppm/6 hour/7 day- intermittent
|
Olfaction: Other olfaction effects | Musculoskeletal: Other changes
TXAPA9 125,214,1994
|
inhalation | rat
lowest published toxic concentration: 592 mg/m3/2.5 hour/2 week- intermittent
|
Behavioral: Food intake (animal) | Liver: Other changes Kidney, Ureter, and Bladder: Other changes
WDZAEK 6,243,1992
|
inhalation | rabbit
lowest published toxic concentration: 85 ppm/7 hour/26 week- intermittent
|
Lung, Thorax, or Respiration: Fibrosis, focal (pneumoconiosis)
|
AIHAAP 37,697,1976
|
oral | mouse
lowest published toxic dose: 1,750 mg/kg/14 day- continuous
|
Liver: Changes in liver weight | Endocrine: Changes in spleen weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
EVHPAZ 46,117,1982
|
oral | mouse
lowest published toxic dose: 560 mg/kg/4 day- intermittent
|
Liver: Hepatitis (hepatocellular necrosis), diffuse | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Kidney, Ureter, and Bladder: Other changes
TOSCF2 50,90,1999
|
oral | mouse
lowest published toxic dose: 9,100 mg/kg/13 week- intermittent
|
Liver: Changes in liver weight | Kidney, Ureter, and Bladder: Other changes Kidney, Ureter, and Bladder: Changes in kidney weight
TOSCF2 50,90,1999
|
oral | rat
lowest published toxic dose: 840 mg/kg/28 day- continuous
|
Blood: Changes in other cell count (unspecified)
|
JPFCD2 17,205,1982
|
oral | rat
lowest published toxic dose: 7,560 mg/kg/21 day- intermittent
|
Liver: Changes in liver weight | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
GISAAA 48(3),10,1983
|
oral | rat
lowest published toxic dose: 5 mg/kg/10 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
TXCYAC 14,23,1979
|
oral | rat
lowest published toxic dose: 37.1 gm/kg/100 week- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TOXID9 72,84,2003
|
oral | rat
lowest published toxic dose: 88.2 gm/kg/100 week- continuous
|
Liver: Other changes
|
TOXID9 72,84,2003
|
oral | rat
lowest published toxic dose: 54 mg/kg/3 day- intermittent
|
Kidney, Ureter, and Bladder: Other changes | Biochemical: Metabolism (intermediary): Other proteins
TXCYAC 180,233,2002
|
oral | rat
lowest published toxic dose: 540 mg/kg/3 day- intermittent
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) | Biochemical: Metabolism (intermediary): Other proteins
TXCYAC 180,233,2002
|
oral | rat
lowest published toxic dose: 3,600 mg/kg/28 day- intermittent
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) | Biochemical: Metabolism (intermediary): Other proteins Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXCYAC 180,233,2002
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 10 ppm
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Confirmed Animal Carcinogen with Unknown
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 20,401,1979
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 73,131,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 20,401,1979
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 73,131,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 2B
|
IMEMDT 73,131,1999
|
TOXICOLOGY REVIEW
|
|
ARZNAD 24,173,1974
|
TOXICOLOGY REVIEW
|
|
AJMEAZ 38,409,1965
|
TOXICOLOGY REVIEW
|
|
FNSCA6 2,67,1973
|
TOXICOLOGY REVIEW
|
|
DCTODJ 1,259,1978
|
TOXICOLOGY REVIEW
|
|
BNYMAM 54,413,1978
|
TOXICOLOGY REVIEW
|
|
CTOXAO 13,231,1978
|
TOXICOLOGY REVIEW
|
|
MUREAV 543,201,2003
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,227,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,109,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,151,2004
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Mine Safety and Health Administration (MSHA) STANDARD
|
air-ceiling concentration 50 ppm (240 mg/m3)
|
DTLWS* 3,14,1973
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)
|
ceiling concentration 50 ppm (240 mg/m3)
|
CFRGBR 29,1910.1000,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
ceiling concentration 50 ppm (240 mg/m3)
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
ceiling concentration 50 ppm (240 mg/m3)
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
ceiling concentration 50 ppm (240 mg/m3)
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - ARAB Republic of Egypt
|
time-weighted average 10 ppm (50 mg/m3), JAN1993
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 10 ppm (50 mg/m3), Carcinogen, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
MAK 10 ppm (50 mg/m3), Suspected Carcinogen, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 10 ppm (49 mg/m3), Carcinogen JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 2 ppm (10 mg/m3), JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 10 ppm (50 mg/m3), short term exposure limit 20 ppm, Skin, Carcinogen, JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 5 ppm (25 mg/m3), VLE 50 ppm (250 mg/m3), continuous3 Carcinogen, JAN1999
|
Occupational Exposure Limit - GERMANY
|
MAK 10 ppm (50 mg/m3), Carcinogen, JAN1999
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 5 mg/m3, 2003
|
Occupational Exposure Limit - INDIA
|
time-weighted average 10 ppm (50 mg/m3), Carcinogen, JAN1993
|
Occupational Exposure Limit - JAPAN
|
Occupational Exposure Limit 10 ppm (49 mg/m3), 2B Carcinogen, JAN1999
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 2 ppm (10 mg/m3), JAN1999
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 50 ppm (240 mg/m3), JAN1993
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 50 mg/m3, MAC(short term exposure limit) 225 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
time-weighted average 50 ppm, JAN1993
|
Occupational Exposure Limit - SWEDEN
|
NGV 2 ppm (10 mg/m3), KTV 5 ppm (25 mg/m3), Carcinogen, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 10 ppm (50 mg/m3), KZG- week 20 ppm (100 mg/m3), JAN1999
|
Occupational Exposure Limit - THAILAND
|
time-weighted average 50 ppm (240 mg/m3), JAN1993
|
Occupational Exposure Limit - TURKEY
|
time-weighted average 50 ppm (240 mg/m3), JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 2 ppm (9.9 mg/m3), Skin, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Confirmed Animal Carcinogen with Unknown
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Confirmed Animal Carcinogen with Unknown |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO CHLOROFORM-air
|
Carcinogen short term exposure limit 2 ppm/60 minute
|
NIOSH* DHHS #92-100,1992
|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO WASTE ANESTHETIC GASES AND VAPORS-air
|
ceiling concentration 2 ppm/1 hour
|
MMWR** 37(S-7),28,1988
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 18500; | Number of Industries 78; Total Number of Facilities 5,120; Number of Occupations 66; Total Number of Employees Exposed 96,747
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 18500; |
Number of Industries 65; Total Number of Facilities 4,890; Number of Occupations 55; Total Number of Employees Exposed 95,773; Total Number of Female Employees Exposed 41,397 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
ATSDR TOXICOLOGY PROFILE (NTIS** PB/98/101140/AS)
|
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat; S cerevisiae gene conversion
|
EPA GENETOX PROGRAM 1988, Positive: S cerevisiae-homozygosis; S cerevisiae-reversion
|
EPA GENETOX PROGRAM 1988, Negative: Cell transform.-SA7/SHE; V79 cell culture-gene mutation
|
EPA GENETOX PROGRAM 1988, Inconclusive: Mammalian micronucleus; Sperm morphology-mouse
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used in the synthesis of FLUOROCARBON 22 for refrigerants, propellants and plastics
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH CURRENT INTELLIGENCE BULLETIN 9, 1976
|
NIOSH Analytical Method, 1994: Hydrocarbons, halogenated, 1003
|
NCI Carcinogenesis Bioassay (gavage);clear evidence:mouse,rat
|
NCITR* NCI-TR,1976
|
NTP 11th Report on Carcinogens,2004:Reasonably anticipated to be a human carcinogen
|
OSHA ANALYTICAL METHOD #05
|
|
REFERENCES:
CODEN
|
|
REFERENCE
85DCAI
|
"Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C.
Thomas, 1970
|
85JCAE
|
"Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia,
Avicenum, 1986
|
AEPPAE
|
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.)
V.110-253, 1925-66. For publisher information, see NSAPCC.
|
AEXPBL
|
Archiv fuer Experimentelle Pathologie und Pharmakologie. (Leipzig, Ger. Dem. Rep.) V.1-109,
1873-1925. For publisher information, see NSAPCC.
|
AGGHAR
|
Archiv fuer Gewerbepathologie und Gewerbehygiene. (Berlin, Ger.) V.1-18, 1930-61. For
publisher information, see IAEHDW.
|
AHBAAM
|
Archiv fuer Hygiene und Bakteriologie. (Munich, Fed. Rep. Ger.) V.101-154, 1929-71. For
publisher information, see ZHPMAT.
|
AIHAAP
|
American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH
44311) V.19- 1958-
|
AJEMEN
|
American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983-
|
AJMEAZ
|
American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1-
1946-
|
ANESAV
|
Anesthesiology. (Lippincott/Harper, Journal Fulfillment Dept., 2350 Virginia Ave.,
Hagerstown, MD 21740) V.1- 1940-
|
ARZNAD
|
Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960
Aulendorf, Fed. Rep. Ger.) V.1- 1951-
|
ATSUDG
|
Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz
Way, Secaucus, NJ 07094) No.1- 1978-
|
BIZEA2
|
Biochemische Zeitschrift. (Berlin, Ger.) V.1-346, 1906-67. For publisher information, see
EJBCAI.
|
BLFSBY
|
Basic Life Sciences. (Plenum Pub. Corp., 223 Spring St., New York, NY 10003) V.1- 1973-
|
BNYMAM
|
Bulletin of the New York Academy of Medicine. (New York Academy of Medicine, 2 E. 103rd St.,
New York, NY 10029) Ser 2: V.1- 1925-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
CTOXAO
|
Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW.
|
DCTODJ
|
Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1-
1977/78-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
DTLWS*
|
"Documentation of the Threshold Limit Values for Substances in Workroom Air," Supplements. For
publisher information, see 85INA8.
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ENVRAL
|
Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-
1967-
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
FAATDF
|
Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1-40, 1981-97. For publisher information, see TOSCF2
|
FLCRAP
|
Fluorine Chemistry Reviews. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1-
1967-
|
FNSCA6
|
Forensic Science. (Lausanne, Switzerland) V.1-11, 1972-78. For pub lisher information, see
FSINDR.
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
IGAYAY
|
Igaku No Ayumi. Progress in Medicine. (Ishiyaku Shuppan K.K., 1-7-10, Honkomagom, Bunkyo-ku,
Tokyo, Japan) V.1- 1946-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
IRGGAJ
|
Internationales Archiv fuer Gewerbepathologie und Gewerbehygiene. (Heidelberg, Fed. Rep.
Ger.) V.19-25, 1962-69. For publisher information, see IAEHDW.
|
JNCIAM
|
Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher
information, see JJIND8.
|
JPETAB
|
Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E.
Preston St., Baltimore, MD 21202) V.1- 1909/10-
|
JPFCD2
|
Journal of Environmental Science and Health, Part B: Pesticides, Food Contaminants, and
Agricultural Wastes. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.B11- 1976-
|
JTSCDR
|
Journal of Toxicological Sciences. (Japanese Soc. of Toxicological Sciences, 4th Floor,
Gakkai Center Bldg., 4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo 113, Japan) V.1- 1976-
|
KHZDAN
|
Khigiena i Zdraveopazvane. Hygiene and Sanitation. (Hemus, Blvd. Russki 6, Sofia, Bulgaria)
V.9- 1966-
|
MMWR**
|
MMWR. Morbidity and Mortality Weekly Report. (Centers for Disease Control, Atlanta, GA 30333)
V.25(10)- 1976- for RTECS citation, only V.34(Suppl 1S), 1985 is used.
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NCITR*
|
National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205.
For publisher information, see NTPTR*.
|
NETOD7
|
Neurobehavioral Toxicology. (Fayetteville, NY) V.1-2, 1979-80. For publisher information,
see NTOTDY.
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
PCOC**
|
Pesticide Chemicals Official Compendium, Association of the American Pesticide Control
Officials, Inc., 1966. (Topeka, KS)
|
PMRSDJ
|
Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New
York, NY 10017) V.1- 1981-
|
QJPPAL
|
Quarterly Journal of Pharmacy & Pharmacology. (London, UK) V.2-21, 1929-48. For publisher
information, see JPPMAB.
|
SHIGAZ
|
Shigaku. Ondotology. (Nippon Shika Daigaku Shigakkai, 1-9-20 Fujimi, Chiyodaku, Tokyo 102,
Japan) V.38- 1949-
|
TABIA2
|
Tabulae Biologicae. (The Hague, Netherlands) V.1-22, 1925-63. Discontinued.
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
VCVGH*
|
"Vrednie chemichescie veshestva, galogenproisvodnie uglevodorodov". (Hazardous substances:
Galogenated hydrocarbons) Bandman A.L. et al., Chimia, 1990.
|
VOONAW
|
Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37; V.1- 1955-
|
WDZAEK
|
Weisheng Dulixue Zazhi. Journal of Health Toxicology. (Weisheng Dulixue Zazhi Bianjibu,
Dongdaqiao, Chaoyang Menwai, Beijing, Peop. Rep. China) V.1- 1987
|
|